Marijuana, immunity and infection

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 102-115

  Klein, Thomas W ^a   Friedman, Herman ^a   Specter, Steven ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cannabinoid; Cannabinoid receptor; Cytokine; Infection; Lymphocyte; Macrophage; Marijuana; NK cell

Indexed keywords

CANNABINOID; CANNABIS; CYTOKINE; DRONABINOL;

ARTICLE; B LYMPHOCYTE; CANNABIS ADDICTION; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOREGULATION; INFECTION; LYMPHOCYTE PROLIFERATION; LYMPHOKINE ACTIVATED KILLER CELL; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BACTERIAL INFECTIONS; CANNABIS; HUMANS; IMMUNE SYSTEM; SUBSTANCE-RELATED DISORDERS;

EID: 0032520698     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00226-9     Document Type: Article

References (91)

1. Arata S., Klein T.W., Newton C., Friedman H. Tetrahydrocannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures. Life Sci. 49:1991;473-479.
2. Ashfaq M.K., Watson E.S., Elsohly H.N. The effect of subacute marijuana smoke inhalation on experimentally-induced dermonecrosis by S.Aureus infection. Immunopharmacol. Immunotoxicol. 9:1987;319-331.
3. 9-tetrahydrocannabinol, cannabinol, and cannabidiol on the immune system in mice: I. In vivo investigation of the primary and secondary immune response. Pharmacology. 26:1983;1-11.
4. 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice: II. In vitro investigation using cultured mouse splenocytes. Pharmacology. 26:1983;12-19.
5. Blanchard D.K., Newton C., Klein T.W., Stewart W.E. III, Friedman H. In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells. Int. J. Immunopharm. 8:1986;819-824.
6. Bradley S.G., Munson A.E., Dewey W.L., Harris L.S. Enhanced susceptibility of mice to combinations of Δ-tetrahydrocannabinol and live or killed gram-negative bacteria. Infect. Immun. 17:1977;325-329.
7. Burnette-Curley D., Marciano-Cabral F., Fischer-Stenger K., Cabral G.A. Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of bacillus Calmette-Guerin-activated macrophages. Int. J. Immunopharm. 15:1993;371-382.
8. Burstein, S., 1991. Cannabinoid-induced changes in eicosanoid synthesis by mouse peritoneal cells. In: Friedman, H., Specter, S., Klein, T.W. (Eds.), Advances in Experimental Medicine and Biology 288, Drugs of Abuse, Immunity, and Immunodeficiency. Plenum, New York, pp. 107-112.
9. Burstein S., Budrow J., Debatis M., Hunter S.A., Subramanian A. Phopholipase participation in cannabinoid-induced release of free arachidonic acid. Biochem. Pharmacol. 48:1994;1253-1264.
10. Cabral G.A., Mishkin E.M. Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. J. Toxicol. Environ. Health. 26:1989;175-182.
11. 9-tetrahydrocannabinol suppresses macrophage extrinsic anti-herpes virus activity. Proc. Soc. Exp. Biol. Med. 199:1992;255-263.
12. 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc. Soc. Exp. Biol. Med. 181:1986;305-311.
13. 9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. Proc. Soc. Exp. Biol. Med. 182:1986;181-186.
14. Cabral G.A., McNerney P.J., Mishkin E.M. Effect of micromolar concentrations of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 replication in vitro. J. Toxicol. Environ. Health. 21:1987;277-293.
15. Cabral G.A., Stinnett A.L., Bailey J., Ali S.F., Paule M.G., Scallet A.C., Slikker W. Chronic marijuana smoke alters alveolar macrophage morphology and protein expression. Pharm. Biochem. Behav. 40:1991;643-649.
16. Clerici M., Shearer G.M. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:1993;107-111.
17. Cushman P., Khurana R. Marijuana and T lymphocyte rosettes. Clin. Pharm. Ther. 19:1976;310-317.
18. Daul C.B., Heath R.G. The effect of chronic marijuana usage on the immunological status of Rhesus monkeys. Life Sci. 17:1975;875-882.
19. Dax E.M., Pilotte N.S., Adler W.H., Nagel J.E., Lange W.R. The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. J. Steroid Biochem. 34:1989;263-270.
20. Derocq J., Segui M., Marchand J., LeFur G., Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 369:1995;177-182.
21. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
22. Diaz S., Specter S., Coffey R.G. Suppression of lymphocyte adenosine 3′:5′-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol. Int. J. Immunopharm. 15:1993;523-532.
23. 9-tetrahydrocannabinol on human neutrophil function. In: Friedman, H., Specter, S., Klein, T.W. (Eds.), Advances in Experimental Medicine and Biology 288, Drugs of Abuse, Immunity, and Immunodeficiency, Vol. 288. Plenum, New York, pp. 57-62.
24. Drath D.B., Shorey J.M., Price L., Huber G.L. Metabolic and functional characteristics of alveolar macrophages recovered from rats exposed to marijuana smoke. Infect. Immun. 25:1979;268-272.
25. 9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells. Proc. Soc. Exp. Biol. Med. 200:1992;422-430.
26. 9-tetrahydrocannabinol inhibition of tumor necrosis factor-α: suppression of post-translational events. J. Pharm. Exp. Ther. 267:1993;1558-1565.
27. Gupta S., Grieco M.H., Cushman P. Impairment of rosette-forming T lymphocytes in chronic marihuana smokers. N. Engl. J. Med. 291:1974;874-876.
28. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Molec. Pharmacol. 29:1986;307-313.
29. Huber G.L., Simmons G.A., McCarthy C.R., Cutting M.B., Laguarda R., Pereira W. Depressant effect of marihuana smoke on antibactericidal activity of pulmonary alveolar macrophages. Chest. 68:1975;769-773.
30. Huber G.L., Pochay V.E., Pereira W., Shea J.W., Hinds W.C., First M.W., Sornberger G.C. Marijuana, tetrahydrocannabinol, and pulmonary antibacterial defenses. Chest. 77:1980;403-410.
31. Juel-Jensen B.E. Cannabis and recurrent herpes simplex. Br. Med. J 4:1972;296.
32. Kaminski N., Koh W.S., Yang K.H., Lee M., Kessler F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharm. 48:1994;1899-1908.
33. Kawakami Y., Klein T.W., Newton C., Djeu J.Y., Specter S., Friedman H. Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. Int. J. Immunopharm. 10:1988;485-488.
34. Kawakami Y., Klein T.W., Newton C., McCarthy C.A., Djeu J., Dennert G., Specter S., Friedman H. Suppression by cannabinoids of a cloned cell line with natural killer cell activity. Proc. Soc. Exp. Biol. Med. 187:1988;355-359.
35. Klein, T.W., Friedman, H., 1990. Modulation of murine immune cell function by marijuana components. In: Watson, R. (Ed.), Drugs of Abuse and Immune Function. CRC Press, Boca Raton, FL, pp. 87-111.
36. Klein T.W., Newton C.A., Widen R., Friedman H. The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T lymphocyte and B lymphocyte mitogen responses. J. Immunopharm. 7:1985;451-466.
37. Klein T.W., Newton C., Friedman H. Inhibition of natural killer cell function by marijuana components. J. Toxicol. Environ. Health. 20:1987;321-332.
38. Klein T.W., Kawakami Y., Newton C., Friedman H. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J. Toxicol. Environ. Health. 32:1991;465-477.
39. 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharmacol. Exp. Ther. 267:1993;635-640.
40. 9-tetrahydrocannabinol, cytokines and immunity to Legionella pneumophila. Proc. Soc. Exp. Biol. Med. 209:1995;205-212.
41. 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell Immunol. 154:1994;99-108.
42. Lancz G., Specter S., Brown H.K. Suppressive effect of delta-9-tetrahydrocannabinol on herpes simplex virus infectivity in vitro. Proc. Soc. Exp. Biol. Med. 196:1991;401-404.
43. 9-tetrahydrocannabinol. Science. 192:1976;805-807.
44. Lee M., Yang K.H., Kaminski N.E. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharm. Exp. Ther. 275:1995;529-536.
45. Lopez-Cepero M., Friedman M., Klein T., Friedman H. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J. Leuk. Biol. 39:1986;679-686.
46. 9-tetrahydrocannabinol does not affect cellular cytotoxicity in vitro. Int. J. Immunopharm. 11:1989;849-852.
47. Luo Y.D., Patel M.K., Wiederhold M.D., Ou D.W. Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int. J. Immunopharm. 14:1992;49-56.
48. Mann P.G., Cohen A.B., Finley T.N., Ladman A.J. Alveolar macrophages: structural and functional differences between nonsmokers and smokers of marijuana and tobacco. Lab. Invest. 25:1971;111-120.
49. 9-tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharm. Exp. Ther. 273:1995;1216-1223.
50. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R., Pertwee R.G., Griffin G., Bayewitch M., Barg J., Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharm. 50:1995;83-90.
51. Mishkin E.M., Cabral G.A. Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse. J. Gen. Virol. 66:1985;2539-2549.
52. Morahan P.S., Klykken P.C., Smith S.H., Harris L.S., Munson A.E. Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. 23:1979;670-674.
53. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
54. Nahas, G.G., Osserman, E.F., 1991. Altered serum immunoglobulin concentration in chronic marijuana smokers. In: Friedman, H., Specter, S., Klein, T.W. (Eds.), Advances in Experimental Medicine and Biology 288, Drugs of Abuse, Immunity and Immunodeficiency. Plenum, New York, pp. 25-32.
55. Nahas G.G., Suciu-Foca N., Armand J.-P., Morishima A. Inhibition of cellular mediated immunity in marihuana smokers. Science. 183:1974;419-420.
56. Nahas G.G., Morishima A., Desoize B. Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes. Fed. Proc. 36:1977;1748-1752.
57. 9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody. Proc. Soc. Exp. Biol. Med. 201:1992;165-168.
58. 9-tetrahydrocannabinol. Int. J. Immunopharm. 15:1993;423-428.
59. Newton C.A., Klein T.W., Friedman H. Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 62:1994;4015-4020.
60. Paradise, L.J., Friedman, H., 1993. Syphilis and drugs of abuse. In: Friedman, H., Klein, T.W., Specter, S. (Eds.), Advances in Experimental Medicine and Biology 335, Drugs of Abuse, Immunity, and AIDS. Plenum, New York, pp. 81-87.
61. 9-tetrahydrocannabinol administration on the plasma catecholamine, β-endorphin, and corticosterone levels and splenic natural killer cell activity in rats. Proc. Soc. Exp. Biol. Med. 180:1985;400-404.
62. Petersen B.H., Graham J., Lemberger L. Marihuana, tetrahydrocannabinol and T-cell function. Life Sci. 19:1976;395-400.
63. Pross S.H., Klein T.W., Newton C.A., Smith J., Widen R., Friedman H. Differential suppression of T-cell subpopulations by THC (delta-9-tetrahydrocannabinol). Int. J. Immunopharm. 12:1990;539-544.
64. Pross S.H., Nakano Y., Widen R., McHugh S., Newton C.A., Klein T.W., Friedman H. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators. Int. J. Immunopharm. 14:1992;1019-1027.
65. Rachelefsky G.S., Opelz G., Mickey M.R., Lessin P., Kiuchi M., Silverstein M.J., Stiehm E.R. Intact humoral and cell-mediated immunity in chronic marijuana smoking. J. Allergy Clin. Immunol. 58:1976;483-490.
66. Reddy M.M., Pinyavat N., Grieco M.H. Interleukin 2 augmentation of natural killer cell activity in homosexual men and acquired immune deficiency syndrome. Infect. Immun. 44:1984;339-343.
67. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrie P., Breliere J.C., LeFur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
68. Schatz A.R., Kessler F.K., Kaminski N.E. Inhibition of adenylate cyclase by 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression. Life Sci. 51:1992;25-30.
69. 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacology. 26:1993;129-137.
70. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 260:1993;496-497.
71. Sherman M.P., Roth M.D., Gong H., Tashkin D.P. Marijuana smoking, pulmonary function, and lung macrophage oxidant release. Pharm. Biochem. Behav. 40:1991;663-669.
72. 9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines. Life Sci. 54:1994;1281-1289.
73. Smith S.H., Harris L.S., Uwaydah I.M., Munson A.E. Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity. J. Pharm. Exp. Ther. 207:1978;165-170.
74. Specter S., Friedman H. Viruses and the immune response. Pharm. Ther. 2:1978;595-622.
75. Specter S., Klein T.W., Newton C., Mondragon M., Widen R., Friedman H. Marijuana effects on immunity: suppression of human natural killer cell activity by delta-9-tetrahydrocannabinol. Int. J. Immunopharm. 8:1986;741-745.
76. Specter S., Lancz G., Hazelden J. Marijuana and immunity: tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis. Int. J. Immunopharm. 12:1990;261-267.
77. 9-tetrahydrocannabinol. J. Leuk. Biol. 50:1991;423-426.
78. Specter, S., Lancz, G., Westrich, G., Friedman, H., 1991. Combined immunosuppressive activities of delta-9-tetrahydrocannabinol and murine retrovirus. In: Friedman, H., Specter, S., Klein, T.W. (Eds.), Advances in Experimental Medicine and Biology, Vol. 288. Plenum, New York, pp. 135-141.
79. Specter S., Lancz G., Westrich G., Friedman H. Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharm. 13:1991;411-417.
80. Tang J.-L., Lancz G., Specter S., Bullock H. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1. Int. J. Immunopharm. 14:1992;253-262.
81. Tang J.-L., Lancz G., Specter S. Delta-9-tetrahydrocannabinol-(THC)-mediated inhibition of macrophage macromolecular metabolism is antagonized by human serum proteins and by cell surface proteins. Int. J. Immunopharm. 15:1993;665-672.
82. Titishov N., Mechoulam R., Zimmerman A.M. Stereospecific effects of (-)- and (+)-7-hydroxy-delta-6-tetrahydrocannabinol-dimethylheptyl on the immune system of mice. Pharmacology. 39:1989;337-349.
83. Wallace J.M., Tashkin D.P., Oishi J.S., Barbers R.G. Peripheral blood lymphocyte subpopulations and mitogen responsiveness in tobacco and marijuana smokers. J. Psychol. Drugs. 20:1988;9-14.
84. Watzl B., Scuder P., Watson R.R. Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro. Int. J. Immunopharm. 13:1991;1091-1097.
85. White S.C., Brin S.C., Janicki B.W. Mitogen-induced responses of lymphocytes from marihuana smokers. Science. 188:1975;71-72.
86. 9-tetrahydrocannabinol suppresses concanavalin A induced increase in cytoplasmic free calcium in mouse thymocytes. Life Sci. 51:1992;151-160.
87. Zheng Z.-M., Specter S., Friedman H. Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharm. 14:1992;1445-1452.
88. Zhu W., Igarashi T., Qi Z.-T., Newton C., Widen R.E., Friedman H., Klein T.W. Delta-9-tetrahydrocannabinol (THC) decreases the number of high and intermediate affinity IL-2 receptors of the IL-2 dependent cell line NKB61A2. Int. J. Immunopharm. 15:1993;401-408.
89. 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages. J. Pharmacol. Exp. Ther. 270:1994;1334-1339.
90. 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits. J. Pharmacol. Exp. Ther. 274:1995;1001-1007.
91. 1-Tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice. Pharmacology. 15:1977;10-23.